Archives of General Psychiatry

• 

  Publication Venue For

  • Neural correlates of food addiction..  68:808-816. 2011
  • Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension..  66:978-985. 2009
  • Predictive value of family history on severity of illness: the case for depression, anxiety, alcohol dependence, and drug dependence..  66:738-747. 2009
  • Role of GABRA2 in trajectories of externalizing behavior across development and evidence of moderation by parental monitoring..  66:649-657. 2009
  • Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety..  66:33-40. 2009
  • Elevated inflammation levels in depressed adults with a history of childhood maltreatment (vol 65, pg 409, 2008).  65:725-725. 2008
  • Elevated inflammation levels in depressed adults with a history of childhood maltreatment..  65:409-415. 2008
  • A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder..  65:203-210. 2008
  • The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes..  64:1132-1143. 2007
  • Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa..  64:1058-1066. 2007
  • Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression..  64:783-792. 2007
  • Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study..  64:689-697. 2007
  • Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism..  64:709-717. 2007
  • Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years..  64:651-660. 2007
  • Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial..  64:633-647. 2007
  • Traumatic events and posttraumatic stress in childhood..  64:577-584. 2007
  • Prediction of differential adult health burden by conduct problem subtypes in males..  64:476-484. 2007
  • Prediction from low birth weight to female adolescent depression: a test of competing hypotheses..  64:338-344. 2007
  • Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation..  63:1396-1406. 2006
  • Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial..  63:1158-1165. 2006
  • Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study..  63:1017-1024. 2006
  • Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors..  63:907-915. 2006
  • Gray and white matter brain chemistry in young children with autism..  63:786-794. 2006
  • Amygdalar volume and behavioral development in autism..  63:686-693. 2006
  • A national study of violent behavior in persons with schizophrenia..  63:490-499. 2006
  • Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: evidence from 2 birth cohorts..  63:462-469. 2006
  • Perspectives on depression, mild cognitive impairment, and cognitive decline..  63:130-138. 2006
  • Cost-effectiveness of improving primary care treatment of late-life depression..  62:1313-1320. 2005
  • Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia..  62:1297-1304. 2005
  • Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years..  62:1366-1376. 2005
  • Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults..  62:1142-1147. 2005
  • Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon..  62:1089-1096. 2005
  • Validation of the phenomenon of autistic regression using home videotapes..  62:889-895. 2005
  • Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction..  62:792-798. 2005
  • Personality and problem gambling: a prospective study of a birth cohort of young adults..  62:769-775. 2005
  • Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not..  62:513-520. 2005
  • Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression..  62:537-544. 2005
  • Strategy for investigating interactions between measured genes and measured environments..  62:473-481. 2005
  • Antipsychotic drug effects on brain morphology in first-episode psychosis..  62:361-370. 2005
  • Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing..  62:254-262. 2005
  • A susceptibility gene for affective disorders and the response of the human amygdala..  62:146-152. 2005
  • Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study..  62:217-224. 2005
  • Maternal depression and children's antisocial behavior: nature and nurture effects..  62:173-181. 2005
  • Contextual predictors of mental health service use among children open to child welfare..  61:1217-1224. 2004
  • Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia..  61:1005-1013. 2004
  • Prenatal smoking and early childhood conduct problems: testing genetic and environmental explanations of the association..  61:836-843. 2004
  • White matter hyperintensity progression and late-life depression outcomes..  60:1090-1096. 2003
  • Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences..  60:817-826. 2003
  • Prevalence and development of psychiatric disorders in childhood and adolescence..  60:837-844. 2003
  • Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life..  60:664-672. 2003
  • Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort..  60:709-717. 2003
  • Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)..  60:82-91. 2003
  • Psychiatric disorder, impairment, and service use in rural African American and white youth..  59:893-901. 2002
  • Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort..  59:449-456. 2002
  • Differences in early childhood risk factors for juvenile-onset and adult-onset depression..  59:215-222. 2002
  • National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders..  59:262-270. 2002
  • Head injury in early adulthood and the lifetime risk of depression..  59:17-22. 2002
  • Antipsychotics and the risk of sudden cardiac death..  58:1161-1167. 2001
  • Handbook of the Sociology of Mental Health.  58:885-885. 2001
  • Quality of medical care and excess mortality in older patients with mental disorders..  58:565-572. 2001
  • Erratum: Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates (Archives of General Psychiatry (February 2001) 58 (199-200)).  58:515. 2001
  • Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder..  58:485-492. 2001
  • Magnetic seizure therapy of major depression..  58:303-305. 2001
  • Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates..  58:199-200. 2001
  • Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates (vol 58, pg 199, 2001).  58:515-515. 2001
  • Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study..  57:1053-1058. 2000
  • Mental disorders and violence in a total birth cohort: results from the Dunedin Study..  57:979-986. 2000
  • Prevalence of depression and its treatment in an elderly population: the Cache County study..  57:601-607. 2000
  • Retrograde amnesia with electroconvulsive therapy: characteristics and implications..  57:591-592. 2000
  • The effects of electroconvulsive therapy on memory of autobiographical and public events..  57:581-590. 2000
  • A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities..  57:425-434. 2000
  • Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects..  57:438-444. 2000
  • Controversies in community-based psychiatric epidemiology: let the data speak for themselves..  57:227-228. 2000
  • Transcranial magnetic stimulation: applications in neuropsychiatry..  56:300-311. 1999
  • Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines..  55:1121-1127. 1998
  • Low-dimensional chaos in bipolar disorder?.  55:275-276. 1998
  • Hypercortisolism associated with social subordinance or social isolation among wild baboons..  54:1137-1143. 1997
  • National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices..  54:865-870. 1997
  • Psychosocial correlates of job strain in a sample of working women..  54:543-548. 1997
  • Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia..  54:169-176. 1997
  • Reduced blue cone electroretinogram in cocaine-withdrawn patients..  54:153-156. 1997
  • The Great Smoky Mountains Study of Youth. Functional impairment and serious emotional disturbance..  53:1137-1143. 1996
  • The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders..  53:1129-1136. 1996
  • Behavioral observations at age 3 years predict adult psychiatric disorders. Longitudinal evidence from a birth cohort..  53:1033-1039. 1996
  • A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia..  53:777-784. 1996
  • Prevalence of psychiatric disorders among incarcerated women. II. Convicted felons entering prison..  53:513-519. 1996
  • The association of sexual assault and attempted suicide within the community..  53:550-555. 1996
  • The role of psychotherapy in the treatment of depression: review of two practice guidelines..  53:298-300. 1996
  • Pharmacotherapy of impaired affect in recovering schizophrenic patients..  52:29. 1995
  • The boundary of social phobia. Exploring the threshold..  51:975-983. 1994
  • A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder..  51:559-567. 1994
  • Clinical practice guidelines. Good news, bad news, or no news?.  50:483-490. 1993
  • Adrenal Gland Enlargement in Major Depression-Reply.  50:834-835. 1993
  • Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study..  50:7-16. 1993
  • Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations..  49:553-557. 1992
  • Adrenal gland enlargement in major depression. A computed tomographic study..  49:384-387. 1992
  • Circulating natural killer cell phenotypes in men and women with major depression. Relation to cytotoxic activity and severity of depression..  49:388-395. 1992
  • Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study..  48:1013-1021. 1991
  • Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence..  48:851-855. 1991
  • Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose..  48:739-745. 1991
  • Lifetime and current prevalence of specific psychiatric disorders among Vietnam veterans and controls..  48:207-215. 1991
  • Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients..  47:634-640. 1990
  • Elevated plasma concentrations of alpha 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients..  47:337-340. 1990
  • Treatment of posttraumatic stress disorder with amitriptyline and placebo..  47:259-266. 1990
  • Children with major depression show reduced rapid eye movement latencies..  47:119-124. 1990
  • In Reply.  47:89-90. 1990
  • Depressive symptoms and depressive diagnoses in a community population. Use of a new procedure for analysis of psychiatric classification..  45:1078-1084. 1988
  • Psychiatric disorders in pediatric primary care. Prevalence and risk factors..  45:1107-1116. 1988
  • One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites..  45:977-986. 1988
  • Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression..  45:919-923. 1988
  • Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia..  45:542-549. 1988
  • Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims..  45:577-579. 1988
  • An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology..  45:120-127. 1988
  • Alcohol abuse and dependence in the rural South..  44:736-740. 1987
  • Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments..  44:152-156. 1987
  • The utility of the dexamethasone suppression test..  44:95-96. 1987
  • Polysomnographic findings in recently drug-free and clinically remitted depressed patients..  43:878-884. 1986
  • Alprazolam vs amitriptyline in depressions with reduced REM latencies..  42:1154-1159. 1985
  • Psychiatric disorders. A rural/urban comparison..  42:651-656. 1985
  • Monoamine oxidase inhibitors in patients with chronic pain..  42:635-636. 1985
  • The 'offset effect' of mental health treatment on ambulatory medical care utilization and charges. Month-by-month and grouped-month analyses of a five-year study..  42:573-580. 1985
  • A sensitive, outpatient dexamethasone suppression test..  42:523-524. 1985
  • Exclusion criteria of DSM-III. A study of co-occurrence of hierarchy-free syndromes..  41:983-989. 1984
  • The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics..  41:934-941. 1984
  • Comparative diagnostic criteria for melancholia and endogenous depression..  41:506-511. 1984
  • The NIMH epidemiologic catchment area program.  41:934-941. 1984
  • Recommendations for depression publications..  40:1031. 1983
  • Atypical depression..  39:527-534. 1982
  • Specialist/generalist division of responsibility for patients with mental disorders..  39:219-224. 1982
  • Use of general medical care services by persons with mental disorders..  39:225-231. 1982
  • Diagnosis and neuroanatomical correlates of depression in brain-damaged patients. Implications for a neurology of depression..  38:1344-1354. 1981
  • Couples training, pharmacotherapy, and behavior therapy in the treatment of obesity..  38:1224-1229. 1981
  • Sexuality in middle and late life. The effects of age, cohort, and gender..  38:919-923. 1981
  • Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up..  38:33-39. 1981
  • Platelet monoamine oxidase activity and the classification of depression..  37:771-773. 1980
  • A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression..  35:639-642. 1978
  • Dimensional diagnosis and the medical student's grasp of psychiatry..  32:525-528. 1975
  • Psychotropic drugs on general medical and surgical wards of a teaching hospital..  32:507-511. 1975
  • Partial REM sleep deprivation, schizophrenia and field articulation..  30:653-662. 1974
  • Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. 2004